In PNAS this week: genetic and proteomic study of the type VII secretion system in tuberculosis, miRNA expression differences in social and solitary locusts, and more.
Researchers get a clear image of the DROSHA protein and gain a better understanding of the Microprocessor complex involved in miRNA biogenesis.
The researchers were able to differentiate among patients with lung cancer, COPD, and health controls using the biomarkers.
The researchers used the tool to look at the role of miRNAs in viral infection, but believe it has potential for studying miRNA in many other contexts.
The company will work with the investigators to examine whether levels of the microRNA can predict patient outcomes to different anti-EGRF therapies.
Members of TCGA characterized papillary renal cell carcinomas, uncovering two main tumor groups and several more prognostically informative subtypes.
In Nature this week: how CRISPR/Cas9 homes in on target, miRNAs involved in cholesterol and triglyceride regulation, and more.
The firm’s increase in sales included a 25 percent jump in sales of Rosetta's core microRNA-based diagnostic assays over the first half of 2014.
The International Thyroid Congress and Annual Meeting of the American Thyroid Association announced studies validating diagnostics tests for several companies.
In Cell this week: method to examine DNA methylation patterns, molecular features of lobular breast cancer, and more.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.